| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,561 |
7,050 |
$592K |
| 99199 |
Unlisted special service, procedure or report |
58,089 |
37,574 |
$355K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,781 |
1,495 |
$114K |
| 83970 |
|
2,482 |
2,106 |
$112K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,510 |
2,138 |
$81K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,965 |
1,606 |
$81K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
319 |
273 |
$32K |
| 80061 |
Lipid panel |
2,312 |
1,960 |
$32K |
| 94375 |
|
1,313 |
1,070 |
$28K |
| 86769 |
|
546 |
437 |
$20K |
| 84480 |
|
1,312 |
1,095 |
$19K |
| 99215 |
Prolong outpt/office vis |
217 |
168 |
$18K |
| 80053 |
Comprehensive metabolic panel |
1,831 |
1,566 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,689 |
1,460 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,636 |
1,398 |
$13K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
150 |
139 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
192 |
129 |
$13K |
| 84439 |
|
1,313 |
1,096 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
650 |
516 |
$12K |
| 99406 |
|
1,514 |
1,216 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
5,677 |
4,280 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
319 |
227 |
$10K |
| 99443 |
|
167 |
103 |
$9K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
124 |
118 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
514 |
442 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
132 |
90 |
$8K |
| 81025 |
|
1,225 |
926 |
$7K |
| 93000 |
|
637 |
533 |
$7K |
| 86703 |
|
442 |
395 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53 |
41 |
$5K |
| 86803 |
|
272 |
248 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
195 |
130 |
$4K |
| 87340 |
|
396 |
343 |
$4K |
| 80050 |
General health panel |
379 |
350 |
$4K |
| 81002 |
|
1,455 |
1,007 |
$2K |
| 82728 |
|
95 |
88 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
106 |
72 |
$1K |
| 99385 |
|
13 |
13 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$1K |
| 83550 |
|
96 |
89 |
$964.05 |
| 82607 |
|
50 |
50 |
$885.24 |
| 82746 |
|
50 |
50 |
$863.31 |
| 99442 |
|
21 |
15 |
$858.62 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
12 |
$645.12 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14 |
13 |
$605.46 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
341 |
252 |
$568.39 |
| 82962 |
|
414 |
283 |
$519.65 |
| 87905 |
|
31 |
29 |
$461.75 |
| 83540 |
|
44 |
38 |
$320.04 |
| 90688 |
|
19 |
13 |
$142.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
13 |
$97.79 |
| 3074F |
|
3,170 |
2,667 |
$9.68 |
| 3048F |
|
419 |
367 |
$9.68 |
| 3078F |
|
2,766 |
2,355 |
$9.67 |
| 3044F |
|
854 |
735 |
$9.67 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
75 |
62 |
$2.47 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
100 |
74 |
$1.14 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
96 |
75 |
$0.03 |
| 4004F |
|
964 |
832 |
$0.00 |
| 3077F |
|
229 |
192 |
$0.00 |
| 1159F |
|
47 |
43 |
$0.00 |
| 3050F |
|
14 |
13 |
$0.00 |
| 3288F |
|
13 |
12 |
$0.00 |
| 3049F |
|
220 |
188 |
$0.00 |
| 3079F |
|
1,103 |
972 |
$0.00 |
| 1170F |
|
48 |
43 |
$0.00 |
| 3008F |
|
3,712 |
3,110 |
$0.00 |
| 3075F |
|
268 |
239 |
$0.00 |
| 3080F |
|
123 |
97 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
45 |
43 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
16 |
14 |
$0.00 |
| 1125F |
|
314 |
289 |
$0.00 |